ImmunoGen
IMGN
#2144
Rank
S$11.30 B
Marketcap
S$40.47
Share price
0.00%
Change (1 day)
126.65%
Change (1 year)

ImmunoGen (IMGN) - Total debt

Total debt on the balance sheet as of September 2023 : S$0.10 Billion

According to ImmunoGen 's latest financial reports the company's total debt is S$0.10 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

ImmunoGen - Total debt on balance sheet (from 1996 to 2023)

Total debt by year

Year Total debt Change
2022-12-31S$20.43 M-19.51%
2021-12-31S$25.39 M-19.66%
2020-12-31S$31.6 M-12.68%
2019-12-31S$36.19 M1183.62%
2018-12-31S$2.81 M2.84%
2017-12-31S$2.74 M
2016-06-30S$0.13 B
2001-06-30S$0.01 M-97.82%
2000-06-30S$0.68 M99.68%
1999-06-30S$0.34 M102.23%
1998-06-30S$0.16 M-41.13%
1997-06-30S$0.28 M-94.8%
1996-06-30S$5.5 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Seagen
SGEN
S$0.14 B 34.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$70.73 B 64,630.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$55.08 B 50,305.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$66.14 B 60,425.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$59.34 B 54,204.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$78.85 B 72,054.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$41.49 B 37,872.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
S$33.08 B 30,175.47%๐Ÿ‡ซ๐Ÿ‡ท France